• ERRα Acetylation Drives RCC Progression via Autophagy Regula

  2026-05-20

  This study uncovers a novel mechanism wherein hypoxia-induced acetylation of ERRα enhances its oncogenic activity in renal cell carcinoma (RCC) by promoting autophagosome-lysosome fusion and sustaining autophagy flux. These findings offer mechanistic insight into RCC progression and suggest new avenues for overcoming sunitinib resistance and targeting autophagy pathways.

• PTX3 Protects Against Glucocorticoid-Induced ONFH via TLR4/N

  2026-05-20

  Li et al. identify pentraxin 3 (PTX3) as a critical modulator that protects against glucocorticoid-induced osteonecrosis of the femoral head (ONFH) by engaging the TLR4/NF-κB/FGF21 signaling axis. Their study delineates mechanistic insight into how PTX3 supplementation preserves bone integrity under glucocorticoid stress, offering a foundation for future therapeutic strategies targeting ER stress and inflammatory bone pathology.

• TG003 Cdc2-like Kinase Inhibitor: Workflows for Splicing Mod

  2026-05-19

  TG003 is redefining research on alternative splicing, platinum resistance, and exon-skipping therapies with its potent, selective inhibition of Clk kinases. This article details experimental strategies, optimization tactics, and troubleshooting insights, leveraging TG003’s unique profile for robust, reproducible results.

• Z-VEID-FMK: Caspase-6 Inhibitor Workflows in Apoptosis Resea

  2026-05-19

  Z-VEID-FMK empowers researchers to dissect caspase-6-dependent apoptosis with precision—enabling reproducible results in neuronal, immune, and cancer models. With robust protocol guidance and troubleshooting strategies, this article unlocks data-driven workflow enhancements for advanced cell death studies.

• IEM 1460: Advanced Workflows for AMPA Receptor Blocker Resea

  2026-05-18

  IEM 1460 stands out as a highly selective AMPA receptor blocker, empowering researchers to unravel synaptic mechanisms and neuroprotection strategies with unmatched specificity. This guide translates recent breakthroughs and hands-on troubleshooting into actionable protocols for reproducible, high-impact neuroscience assays.

• Catalpol Modulates Hepatic Energy Metabolism via SIRT1/HIF-1

  2026-05-18

  This study demonstrates that catalpol mitigates triptolide-induced liver injury by restoring mitochondrial energy metabolism and reducing oxidative stress through SIRT1 activation and inhibition of HIF-1α acetylation. These findings uncover new mechanistic insights for managing drug-induced hepatotoxicity and highlight the importance of mitochondrial function in liver protection.

• Live-Dead Cell Staining Kit: Precision in Calcein-AM Propidi

  2026-05-17

  The APExBIO Live-Dead Cell Staining Kit enables robust, dual-fluorescent discrimination of live and dead cells, streamlining complex viability and cytotoxicity assays. By leveraging Calcein-AM Propidium Iodide staining, researchers gain reproducible, quantitative insights across flow cytometry, fluorescence microscopy, and advanced biomaterial validation.

• KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyros

  2026-05-16

  This article delivers a scenario-driven, evidence-based exploration of KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine (SKU A8180) for researchers studying calcium signaling, cell cycle, and metabolic regulation. Focusing on reproducibility and practical workflow optimization, it distills best practices for deploying this selective CaMKII inhibitor in cell viability and functional assays.

• 5-Methyl-CTP: Enhancing mRNA Synthesis and Vaccine Stability

  2026-05-15

  5-Methyl-CTP empowers researchers to synthesize mRNA with superior stability and translational efficiency, enabling robust results in gene expression and next-generation vaccine development. Learn how to optimize your protocols, troubleshoot common pitfalls, and leverage recent breakthroughs illustrated by the protective mRNA vaccine response in livestock.

• Oral Dextran Microgels for Targeted Colorectal Cancer Therap

  2026-05-15

  This article reviews the innovation of dextran microgels loaded with cisplatin/SPION lipid nanotherapeutics for oral, colon-targeted colorectal cancer treatment. The system achieves dual targeting, enhanced local retention, and effective tumor inhibition, highlighting a new direction for localized chemotherapeutic delivery.

• Scalable EPSC-iMSC EV Production for Regenerative Therapy

  2026-05-14

  This study presents a bioreactor-based, scalable platform for producing extracellular vesicles (EVs) from extended pluripotent stem cell-derived mesenchymal stem cells (EPSC-iMSCs), addressing major bottlenecks in EV therapeutics. The approach yields high-quality, standardized EVs with demonstrated efficacy in a pulmonary fibrosis model, paving the way for clinical-grade regenerative therapies.

• Next-Generation Hydrophilic Dye Labeling: Translational Insi

  2026-05-14

  Explore how Sulfo-Cy3 NHS Ester's hydrophilic design is revolutionizing fluorescent labeling for translational vascular research. This thought-leadership article integrates mechanistic insight from recent vascular remodeling studies, competitive benchmarking, and protocol guidance for researchers seeking robust, reproducible labeling solutions.

• Annexin V-FITC/PI Apoptosis Assay Kit: Precision in Nanotoxi

  2026-05-13

  Explore how the Annexin V-FITC/PI Apoptosis Assay Kit enables advanced, quantitative apoptosis detection in nanotoxicology and mitochondrial dysfunction studies. This article uniquely integrates recent reference findings and nuanced assay optimization strategies.

• Biotin-XX Tyramide Reagent: Cell Surface Profiling Enhanced

  2026-05-13

  Biotin-XX Tyramide Reagent unlocks ultra-sensitive, membrane-impermeant proximity labeling for precise cell surface protein profiling. Its unique chemistry and optimized amplification workflows empower reproducible detection of low-abundance targets in IHC and ISH, outperforming standard tyramide probes in signal specificity and background reduction.

• Nystatin (Fungicidin): Mechanisms, Resistance, and Translati

  2026-05-12

  This article delivers a thought-leadership perspective for translational researchers on leveraging Nystatin (Fungicidin) as a mechanistically-defined antifungal agent. We synthesize cutting-edge mechanistic insight, highlight real-world assay parameters, and critically discuss antifungal resistance, bridging primary literature with strategic workflow guidance. By integrating evidence from both peer-reviewed research and APExBIO product intelligence, we map new opportunities for innovation in Candida and Aspergillus research.

14675 records 1/979 page Next 12345 下5页 Last page